Close

Barclays Maintains an 'Overweight' on Sequenom (SQNM); Analyst Day Sets Initial T21 Expectations Nov 15, 2011 01:46PM
Barclays Maintains an 'Overweight' on Sequenom (SQNM); MaterniT21 Launches with Publication of Validation Study Results Oct 18, 2011 01:32PM
Barclays on U.S. Diagnostics: Policy, Macro Overhang Persists in Q3 Oct 17, 2011 02:50PM
Barclays Reiterates an 'Overweight' on Sequenom (SQNM); Management Meeting Takeaways Sep 28, 2011 01:01PM
Barclays on U.S. Diagnostics: Q2 Preview; 2H Volume Recovery Likely Slower Than Expected Jul 19, 2011 01:57PM


Jul 7, 2011 02:02PM Barclays Maintains an 'Overweight' on Sequenom (SQNM); Lo Publishes Data on T-13/T-18 Detection
Apr 11, 2011 02:43PM Barclays on U.S. Diagnostics: Q1 2011 Preview
Mar 9, 2011 01:27PM Barclays Maintains an 'Overweight' on Sequenom (SQNM); Q4 Review: T21 on Track, Cash Adequate
Jan 13, 2011 01:20PM Barclays Maintains an 'Overweight' on Sequenom (SQNM); Dennis Lo's Data Reads Out As Expected
May 24, 2010 11:19AM Sequenom (SQNM) volatility elevated at 103
May 24, 2010 09:00AM Sequenom (SQNM): Bullish on the technology and Sequenom's prospects for commercializing T-21 in 2011 - Barclays
Apr 7, 2010 10:46AM Notable Analyst Rating Changes 04/07: NOK, KEY, AIB, IRE, DRI Upgraded; LVS, NFLX, SNH Downgraded
Mar 16, 2010 10:39AM Notable Analyst Rating Changes 03/16: SBUX, CLX, MPEL, UFS Upgraded; BSX, SQNM, WU, EAT Downgraded
Mar 2, 2010 10:11AM Notable Analyst Rating Changes 03/02: DELL, MRVL, SNDK, SQNM Upgraded; KMB, NUHC, OSIP, PALM Downgraded